FREE RADICAL BIOLOGY AND MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1003572, encodeId=8a5510035e255, content=审稿速度:1.0 经验分享：6.24投稿，大约三周后收到消息补实验，给了两周时间，7月26修回，7月28接受。 这个杂志效率真的是太高了！强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2de25503729, createdName=ms3000000842187804, createdTime=Thu Jul 29 11:46:38 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197254, encodeId=de69119e254a2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：代谢;线粒体 经验分享：好杂志，要求原始数据，对机制要求深入, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aca03683052, createdName=134836ccm20暂无昵称, createdTime=Fri Feb 25 16:24:11 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588801, encodeId=4012588801fb, content=2月4号投稿,7号under review，3月16号修回，两个审稿人，每个人大概五六条意见，有一个审稿人要补充氧化应激方面的数据。3月23号修回，25号二次under review，3月31显示收到审稿意见，一直是等待decision，可能是清明节的原因，4月7号收到二次修改的意见，是让补充一下discussion，4月7当天修回，第二天under review，10号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/31/9ef441156d9cc703cacfd553dc8eb7e5.jpg, createdBy=0c895210311, createdName=4475b18am4暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180178, encodeId=15fe21801e860, content=偏重的研究方向：氧化应激;ROS 经验分享：1.7 submittef，1.8号 with editor, 1.9号 under review,接好运啊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 09 06:57:12 CST 2024, time=2024-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907064, encodeId=9e9790e06425, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：炎症;肠道菌群;代谢 经验分享：从投稿到一审结束大约3周，修稿2月后返回，二审又3周，直接接收，10天后online.个人觉得这个杂志审稿效率很高，编辑给的意见很中肯，版面费稍贵，2万多人民币。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bad85222745, createdName=14782f76m64(暂无昵称), createdTime=Fri Dec 11 14:42:22 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166938, encodeId=69ab216693802, content=审稿速度:1.0 经验分享：with editor一个月被desk rejected, 一点意见都没有，真恶心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=bmcmgnmslsb88888, createdTime=Mon Nov 06 01:35:55 CST 2023, time=2023-11-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2122387, encodeId=0c7a212238e2e, content=偏重的研究方向：炎症;药物氧化应激;心血管 经验分享：2023年3月24号投稿，26号让稍微修改下文章，将figure 9以graphic abstract上传后重新投稿，3月27号状态变为“with editor”，28号给了个稿号，with editor等待外审中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94946415536, createdName=ms7000001540185333, createdTime=Wed Mar 29 00:39:50 CST 2023, time=2023-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582040, encodeId=614a582040f5, content=with editor 10多天了，没动静，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7d1625606, createdName=firestar, createdTime=Mon Dec 23 17:19:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550274, encodeId=71405502e478, content=想问下推荐的4个审稿人怎么填写？还有E-mail Address，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68552230471, createdName=121212cbm79(暂无昵称), createdTime=Sat Dec 23 18:16:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013354, encodeId=64f9101335460, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：ROS;Liver disease;Autophagy 经验分享：2021.07.15 Initial Date Submitted 2021.07.16 Under Review 2021.07.23 Required Reviews Completed 2021.08.07 with editor 2021.08.09 Under review 2021.08.30 Required Reviews Completed 2021.08.30 Decision in Process 2021.08.30 Accept 非常高效！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/a185abdd38e94c8ca932a187b8624780/e108d18813c84be0af15f044f2da2f8a.PNG, createdBy=44821626617, createdName=huqiaoting, createdTime=Wed Sep 01 02:28:23 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2021-07-29 ms3000000842187804

审稿速度:1.0
经验分享：6.24投稿，大约三周后收到消息补实验，给了两周时间，7月26修回，7月28接受。
这个杂志效率真的是太高了！强烈推荐。

67 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1003572, encodeId=8a5510035e255, content=审稿速度:1.0 经验分享：6.24投稿，大约三周后收到消息补实验，给了两周时间，7月26修回，7月28接受。 这个杂志效率真的是太高了！强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2de25503729, createdName=ms3000000842187804, createdTime=Thu Jul 29 11:46:38 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197254, encodeId=de69119e254a2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：代谢;线粒体 经验分享：好杂志，要求原始数据，对机制要求深入, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aca03683052, createdName=134836ccm20暂无昵称, createdTime=Fri Feb 25 16:24:11 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588801, encodeId=4012588801fb, content=2月4号投稿,7号under review，3月16号修回，两个审稿人，每个人大概五六条意见，有一个审稿人要补充氧化应激方面的数据。3月23号修回，25号二次under review，3月31显示收到审稿意见，一直是等待decision，可能是清明节的原因，4月7号收到二次修改的意见，是让补充一下discussion，4月7当天修回，第二天under review，10号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/31/9ef441156d9cc703cacfd553dc8eb7e5.jpg, createdBy=0c895210311, createdName=4475b18am4暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180178, encodeId=15fe21801e860, content=偏重的研究方向：氧化应激;ROS 经验分享：1.7 submittef，1.8号 with editor, 1.9号 under review,接好运啊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 09 06:57:12 CST 2024, time=2024-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907064, encodeId=9e9790e06425, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：炎症;肠道菌群;代谢 经验分享：从投稿到一审结束大约3周，修稿2月后返回，二审又3周，直接接收，10天后online.个人觉得这个杂志审稿效率很高，编辑给的意见很中肯，版面费稍贵，2万多人民币。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bad85222745, createdName=14782f76m64(暂无昵称), createdTime=Fri Dec 11 14:42:22 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166938, encodeId=69ab216693802, content=审稿速度:1.0 经验分享：with editor一个月被desk rejected, 一点意见都没有，真恶心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=bmcmgnmslsb88888, createdTime=Mon Nov 06 01:35:55 CST 2023, time=2023-11-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2122387, encodeId=0c7a212238e2e, content=偏重的研究方向：炎症;药物氧化应激;心血管 经验分享：2023年3月24号投稿，26号让稍微修改下文章，将figure 9以graphic abstract上传后重新投稿，3月27号状态变为“with editor”，28号给了个稿号，with editor等待外审中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94946415536, createdName=ms7000001540185333, createdTime=Wed Mar 29 00:39:50 CST 2023, time=2023-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582040, encodeId=614a582040f5, content=with editor 10多天了，没动静，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7d1625606, createdName=firestar, createdTime=Mon Dec 23 17:19:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550274, encodeId=71405502e478, content=想问下推荐的4个审稿人怎么填写？还有E-mail Address，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68552230471, createdName=121212cbm79(暂无昵称), createdTime=Sat Dec 23 18:16:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013354, encodeId=64f9101335460, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：ROS;Liver disease;Autophagy 经验分享：2021.07.15 Initial Date Submitted 2021.07.16 Under Review 2021.07.23 Required Reviews Completed 2021.08.07 with editor 2021.08.09 Under review 2021.08.30 Required Reviews Completed 2021.08.30 Decision in Process 2021.08.30 Accept 非常高效！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/a185abdd38e94c8ca932a187b8624780/e108d18813c84be0af15f044f2da2f8a.PNG, createdBy=44821626617, createdName=huqiaoting, createdTime=Wed Sep 01 02:28:23 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2022-02-25 134836ccm20暂无昵称

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：代谢;线粒体
经验分享：好杂志，要求原始数据，对机制要求深入

46 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1003572, encodeId=8a5510035e255, content=审稿速度:1.0 经验分享：6.24投稿，大约三周后收到消息补实验，给了两周时间，7月26修回，7月28接受。 这个杂志效率真的是太高了！强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2de25503729, createdName=ms3000000842187804, createdTime=Thu Jul 29 11:46:38 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197254, encodeId=de69119e254a2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：代谢;线粒体 经验分享：好杂志，要求原始数据，对机制要求深入, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aca03683052, createdName=134836ccm20暂无昵称, createdTime=Fri Feb 25 16:24:11 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588801, encodeId=4012588801fb, content=2月4号投稿,7号under review，3月16号修回，两个审稿人，每个人大概五六条意见，有一个审稿人要补充氧化应激方面的数据。3月23号修回，25号二次under review，3月31显示收到审稿意见，一直是等待decision，可能是清明节的原因，4月7号收到二次修改的意见，是让补充一下discussion，4月7当天修回，第二天under review，10号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/31/9ef441156d9cc703cacfd553dc8eb7e5.jpg, createdBy=0c895210311, createdName=4475b18am4暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180178, encodeId=15fe21801e860, content=偏重的研究方向：氧化应激;ROS 经验分享：1.7 submittef，1.8号 with editor, 1.9号 under review,接好运啊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 09 06:57:12 CST 2024, time=2024-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907064, encodeId=9e9790e06425, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：炎症;肠道菌群;代谢 经验分享：从投稿到一审结束大约3周，修稿2月后返回，二审又3周，直接接收，10天后online.个人觉得这个杂志审稿效率很高，编辑给的意见很中肯，版面费稍贵，2万多人民币。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bad85222745, createdName=14782f76m64(暂无昵称), createdTime=Fri Dec 11 14:42:22 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166938, encodeId=69ab216693802, content=审稿速度:1.0 经验分享：with editor一个月被desk rejected, 一点意见都没有，真恶心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=bmcmgnmslsb88888, createdTime=Mon Nov 06 01:35:55 CST 2023, time=2023-11-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2122387, encodeId=0c7a212238e2e, content=偏重的研究方向：炎症;药物氧化应激;心血管 经验分享：2023年3月24号投稿，26号让稍微修改下文章，将figure 9以graphic abstract上传后重新投稿，3月27号状态变为“with editor”，28号给了个稿号，with editor等待外审中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94946415536, createdName=ms7000001540185333, createdTime=Wed Mar 29 00:39:50 CST 2023, time=2023-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582040, encodeId=614a582040f5, content=with editor 10多天了，没动静，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7d1625606, createdName=firestar, createdTime=Mon Dec 23 17:19:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550274, encodeId=71405502e478, content=想问下推荐的4个审稿人怎么填写？还有E-mail Address，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68552230471, createdName=121212cbm79(暂无昵称), createdTime=Sat Dec 23 18:16:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013354, encodeId=64f9101335460, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：ROS;Liver disease;Autophagy 经验分享：2021.07.15 Initial Date Submitted 2021.07.16 Under Review 2021.07.23 Required Reviews Completed 2021.08.07 with editor 2021.08.09 Under review 2021.08.30 Required Reviews Completed 2021.08.30 Decision in Process 2021.08.30 Accept 非常高效！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/a185abdd38e94c8ca932a187b8624780/e108d18813c84be0af15f044f2da2f8a.PNG, createdBy=44821626617, createdName=huqiaoting, createdTime=Wed Sep 01 02:28:23 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2020-04-14 4475b18am4暂无昵称

2月4号投稿,7号under review，3月16号修回，两个审稿人，每个人大概五六条意见，有一个审稿人要补充氧化应激方面的数据。3月23号修回，25号二次under review，3月31显示收到审稿意见，一直是等待decision，可能是清明节的原因，4月7号收到二次修改的意见，是让补充一下discussion，4月7当天修回，第二天under review，10号接收

203 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1003572, encodeId=8a5510035e255, content=审稿速度:1.0 经验分享：6.24投稿，大约三周后收到消息补实验，给了两周时间，7月26修回，7月28接受。 这个杂志效率真的是太高了！强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2de25503729, createdName=ms3000000842187804, createdTime=Thu Jul 29 11:46:38 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197254, encodeId=de69119e254a2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：代谢;线粒体 经验分享：好杂志，要求原始数据，对机制要求深入, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aca03683052, createdName=134836ccm20暂无昵称, createdTime=Fri Feb 25 16:24:11 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588801, encodeId=4012588801fb, content=2月4号投稿,7号under review，3月16号修回，两个审稿人，每个人大概五六条意见，有一个审稿人要补充氧化应激方面的数据。3月23号修回，25号二次under review，3月31显示收到审稿意见，一直是等待decision，可能是清明节的原因，4月7号收到二次修改的意见，是让补充一下discussion，4月7当天修回，第二天under review，10号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/31/9ef441156d9cc703cacfd553dc8eb7e5.jpg, createdBy=0c895210311, createdName=4475b18am4暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180178, encodeId=15fe21801e860, content=偏重的研究方向：氧化应激;ROS 经验分享：1.7 submittef，1.8号 with editor, 1.9号 under review,接好运啊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 09 06:57:12 CST 2024, time=2024-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907064, encodeId=9e9790e06425, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：炎症;肠道菌群;代谢 经验分享：从投稿到一审结束大约3周，修稿2月后返回，二审又3周，直接接收，10天后online.个人觉得这个杂志审稿效率很高，编辑给的意见很中肯，版面费稍贵，2万多人民币。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bad85222745, createdName=14782f76m64(暂无昵称), createdTime=Fri Dec 11 14:42:22 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166938, encodeId=69ab216693802, content=审稿速度:1.0 经验分享：with editor一个月被desk rejected, 一点意见都没有，真恶心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=bmcmgnmslsb88888, createdTime=Mon Nov 06 01:35:55 CST 2023, time=2023-11-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2122387, encodeId=0c7a212238e2e, content=偏重的研究方向：炎症;药物氧化应激;心血管 经验分享：2023年3月24号投稿，26号让稍微修改下文章，将figure 9以graphic abstract上传后重新投稿，3月27号状态变为“with editor”，28号给了个稿号，with editor等待外审中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94946415536, createdName=ms7000001540185333, createdTime=Wed Mar 29 00:39:50 CST 2023, time=2023-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582040, encodeId=614a582040f5, content=with editor 10多天了，没动静，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7d1625606, createdName=firestar, createdTime=Mon Dec 23 17:19:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550274, encodeId=71405502e478, content=想问下推荐的4个审稿人怎么填写？还有E-mail Address，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68552230471, createdName=121212cbm79(暂无昵称), createdTime=Sat Dec 23 18:16:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013354, encodeId=64f9101335460, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：ROS;Liver disease;Autophagy 经验分享：2021.07.15 Initial Date Submitted 2021.07.16 Under Review 2021.07.23 Required Reviews Completed 2021.08.07 with editor 2021.08.09 Under review 2021.08.30 Required Reviews Completed 2021.08.30 Decision in Process 2021.08.30 Accept 非常高效！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/a185abdd38e94c8ca932a187b8624780/e108d18813c84be0af15f044f2da2f8a.PNG, createdBy=44821626617, createdName=huqiaoting, createdTime=Wed Sep 01 02:28:23 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2024-01-09 594624370

偏重的研究方向：氧化应激;ROS
经验分享：1.7 submittef，1.8号 with editor, 1.9号 under review,接好运啊！！

24 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1003572, encodeId=8a5510035e255, content=审稿速度:1.0 经验分享：6.24投稿，大约三周后收到消息补实验，给了两周时间，7月26修回，7月28接受。 这个杂志效率真的是太高了！强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2de25503729, createdName=ms3000000842187804, createdTime=Thu Jul 29 11:46:38 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197254, encodeId=de69119e254a2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：代谢;线粒体 经验分享：好杂志，要求原始数据，对机制要求深入, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aca03683052, createdName=134836ccm20暂无昵称, createdTime=Fri Feb 25 16:24:11 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588801, encodeId=4012588801fb, content=2月4号投稿,7号under review，3月16号修回，两个审稿人，每个人大概五六条意见，有一个审稿人要补充氧化应激方面的数据。3月23号修回，25号二次under review，3月31显示收到审稿意见，一直是等待decision，可能是清明节的原因，4月7号收到二次修改的意见，是让补充一下discussion，4月7当天修回，第二天under review，10号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/31/9ef441156d9cc703cacfd553dc8eb7e5.jpg, createdBy=0c895210311, createdName=4475b18am4暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180178, encodeId=15fe21801e860, content=偏重的研究方向：氧化应激;ROS 经验分享：1.7 submittef，1.8号 with editor, 1.9号 under review,接好运啊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 09 06:57:12 CST 2024, time=2024-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907064, encodeId=9e9790e06425, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：炎症;肠道菌群;代谢 经验分享：从投稿到一审结束大约3周，修稿2月后返回，二审又3周，直接接收，10天后online.个人觉得这个杂志审稿效率很高，编辑给的意见很中肯，版面费稍贵，2万多人民币。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bad85222745, createdName=14782f76m64(暂无昵称), createdTime=Fri Dec 11 14:42:22 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166938, encodeId=69ab216693802, content=审稿速度:1.0 经验分享：with editor一个月被desk rejected, 一点意见都没有，真恶心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=bmcmgnmslsb88888, createdTime=Mon Nov 06 01:35:55 CST 2023, time=2023-11-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2122387, encodeId=0c7a212238e2e, content=偏重的研究方向：炎症;药物氧化应激;心血管 经验分享：2023年3月24号投稿，26号让稍微修改下文章，将figure 9以graphic abstract上传后重新投稿，3月27号状态变为“with editor”，28号给了个稿号，with editor等待外审中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94946415536, createdName=ms7000001540185333, createdTime=Wed Mar 29 00:39:50 CST 2023, time=2023-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582040, encodeId=614a582040f5, content=with editor 10多天了，没动静，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7d1625606, createdName=firestar, createdTime=Mon Dec 23 17:19:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550274, encodeId=71405502e478, content=想问下推荐的4个审稿人怎么填写？还有E-mail Address，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68552230471, createdName=121212cbm79(暂无昵称), createdTime=Sat Dec 23 18:16:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013354, encodeId=64f9101335460, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：ROS;Liver disease;Autophagy 经验分享：2021.07.15 Initial Date Submitted 2021.07.16 Under Review 2021.07.23 Required Reviews Completed 2021.08.07 with editor 2021.08.09 Under review 2021.08.30 Required Reviews Completed 2021.08.30 Decision in Process 2021.08.30 Accept 非常高效！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/a185abdd38e94c8ca932a187b8624780/e108d18813c84be0af15f044f2da2f8a.PNG, createdBy=44821626617, createdName=huqiaoting, createdTime=Wed Sep 01 02:28:23 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2020-12-11 14782f76m64(暂无昵称)

审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0
偏重的研究方向：炎症;肠道菌群;代谢
经验分享：从投稿到一审结束大约3周，修稿2月后返回，二审又3周，直接接收，10天后online.个人觉得这个杂志审稿效率很高，编辑给的意见很中肯，版面费稍贵，2万多人民币。

140 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1003572, encodeId=8a5510035e255, content=审稿速度:1.0 经验分享：6.24投稿，大约三周后收到消息补实验，给了两周时间，7月26修回，7月28接受。 这个杂志效率真的是太高了！强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2de25503729, createdName=ms3000000842187804, createdTime=Thu Jul 29 11:46:38 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197254, encodeId=de69119e254a2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：代谢;线粒体 经验分享：好杂志，要求原始数据，对机制要求深入, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aca03683052, createdName=134836ccm20暂无昵称, createdTime=Fri Feb 25 16:24:11 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588801, encodeId=4012588801fb, content=2月4号投稿,7号under review，3月16号修回，两个审稿人，每个人大概五六条意见，有一个审稿人要补充氧化应激方面的数据。3月23号修回，25号二次under review，3月31显示收到审稿意见，一直是等待decision，可能是清明节的原因，4月7号收到二次修改的意见，是让补充一下discussion，4月7当天修回，第二天under review，10号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/31/9ef441156d9cc703cacfd553dc8eb7e5.jpg, createdBy=0c895210311, createdName=4475b18am4暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180178, encodeId=15fe21801e860, content=偏重的研究方向：氧化应激;ROS 经验分享：1.7 submittef，1.8号 with editor, 1.9号 under review,接好运啊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 09 06:57:12 CST 2024, time=2024-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907064, encodeId=9e9790e06425, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：炎症;肠道菌群;代谢 经验分享：从投稿到一审结束大约3周，修稿2月后返回，二审又3周，直接接收，10天后online.个人觉得这个杂志审稿效率很高，编辑给的意见很中肯，版面费稍贵，2万多人民币。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bad85222745, createdName=14782f76m64(暂无昵称), createdTime=Fri Dec 11 14:42:22 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166938, encodeId=69ab216693802, content=审稿速度:1.0 经验分享：with editor一个月被desk rejected, 一点意见都没有，真恶心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=bmcmgnmslsb88888, createdTime=Mon Nov 06 01:35:55 CST 2023, time=2023-11-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2122387, encodeId=0c7a212238e2e, content=偏重的研究方向：炎症;药物氧化应激;心血管 经验分享：2023年3月24号投稿，26号让稍微修改下文章，将figure 9以graphic abstract上传后重新投稿，3月27号状态变为“with editor”，28号给了个稿号，with editor等待外审中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94946415536, createdName=ms7000001540185333, createdTime=Wed Mar 29 00:39:50 CST 2023, time=2023-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582040, encodeId=614a582040f5, content=with editor 10多天了，没动静，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7d1625606, createdName=firestar, createdTime=Mon Dec 23 17:19:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550274, encodeId=71405502e478, content=想问下推荐的4个审稿人怎么填写？还有E-mail Address，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68552230471, createdName=121212cbm79(暂无昵称), createdTime=Sat Dec 23 18:16:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013354, encodeId=64f9101335460, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：ROS;Liver disease;Autophagy 经验分享：2021.07.15 Initial Date Submitted 2021.07.16 Under Review 2021.07.23 Required Reviews Completed 2021.08.07 with editor 2021.08.09 Under review 2021.08.30 Required Reviews Completed 2021.08.30 Decision in Process 2021.08.30 Accept 非常高效！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/a185abdd38e94c8ca932a187b8624780/e108d18813c84be0af15f044f2da2f8a.PNG, createdBy=44821626617, createdName=huqiaoting, createdTime=Wed Sep 01 02:28:23 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2023-11-06 bmcmgnmslsb88888 来自陕西省

审稿速度:1.0
经验分享：with editor一个月被desk rejected, 一点意见都没有，真恶心。

25 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1003572, encodeId=8a5510035e255, content=审稿速度:1.0 经验分享：6.24投稿，大约三周后收到消息补实验，给了两周时间，7月26修回，7月28接受。 这个杂志效率真的是太高了！强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2de25503729, createdName=ms3000000842187804, createdTime=Thu Jul 29 11:46:38 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197254, encodeId=de69119e254a2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：代谢;线粒体 经验分享：好杂志，要求原始数据，对机制要求深入, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aca03683052, createdName=134836ccm20暂无昵称, createdTime=Fri Feb 25 16:24:11 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588801, encodeId=4012588801fb, content=2月4号投稿,7号under review，3月16号修回，两个审稿人，每个人大概五六条意见，有一个审稿人要补充氧化应激方面的数据。3月23号修回，25号二次under review，3月31显示收到审稿意见，一直是等待decision，可能是清明节的原因，4月7号收到二次修改的意见，是让补充一下discussion，4月7当天修回，第二天under review，10号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/31/9ef441156d9cc703cacfd553dc8eb7e5.jpg, createdBy=0c895210311, createdName=4475b18am4暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180178, encodeId=15fe21801e860, content=偏重的研究方向：氧化应激;ROS 经验分享：1.7 submittef，1.8号 with editor, 1.9号 under review,接好运啊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 09 06:57:12 CST 2024, time=2024-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907064, encodeId=9e9790e06425, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：炎症;肠道菌群;代谢 经验分享：从投稿到一审结束大约3周，修稿2月后返回，二审又3周，直接接收，10天后online.个人觉得这个杂志审稿效率很高，编辑给的意见很中肯，版面费稍贵，2万多人民币。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bad85222745, createdName=14782f76m64(暂无昵称), createdTime=Fri Dec 11 14:42:22 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166938, encodeId=69ab216693802, content=审稿速度:1.0 经验分享：with editor一个月被desk rejected, 一点意见都没有，真恶心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=bmcmgnmslsb88888, createdTime=Mon Nov 06 01:35:55 CST 2023, time=2023-11-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2122387, encodeId=0c7a212238e2e, content=偏重的研究方向：炎症;药物氧化应激;心血管 经验分享：2023年3月24号投稿，26号让稍微修改下文章，将figure 9以graphic abstract上传后重新投稿，3月27号状态变为“with editor”，28号给了个稿号，with editor等待外审中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94946415536, createdName=ms7000001540185333, createdTime=Wed Mar 29 00:39:50 CST 2023, time=2023-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582040, encodeId=614a582040f5, content=with editor 10多天了，没动静，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7d1625606, createdName=firestar, createdTime=Mon Dec 23 17:19:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550274, encodeId=71405502e478, content=想问下推荐的4个审稿人怎么填写？还有E-mail Address，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68552230471, createdName=121212cbm79(暂无昵称), createdTime=Sat Dec 23 18:16:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013354, encodeId=64f9101335460, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：ROS;Liver disease;Autophagy 经验分享：2021.07.15 Initial Date Submitted 2021.07.16 Under Review 2021.07.23 Required Reviews Completed 2021.08.07 with editor 2021.08.09 Under review 2021.08.30 Required Reviews Completed 2021.08.30 Decision in Process 2021.08.30 Accept 非常高效！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/a185abdd38e94c8ca932a187b8624780/e108d18813c84be0af15f044f2da2f8a.PNG, createdBy=44821626617, createdName=huqiaoting, createdTime=Wed Sep 01 02:28:23 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2023-03-29 ms7000001540185333 来自湖北省

偏重的研究方向：炎症;药物氧化应激;心血管
经验分享：2023年3月24号投稿，26号让稍微修改下文章，将figure 9以graphic abstract上传后重新投稿，3月27号状态变为“with editor”，28号给了个稿号，with editor等待外审中

33 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1003572, encodeId=8a5510035e255, content=审稿速度:1.0 经验分享：6.24投稿，大约三周后收到消息补实验，给了两周时间，7月26修回，7月28接受。 这个杂志效率真的是太高了！强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2de25503729, createdName=ms3000000842187804, createdTime=Thu Jul 29 11:46:38 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197254, encodeId=de69119e254a2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：代谢;线粒体 经验分享：好杂志，要求原始数据，对机制要求深入, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aca03683052, createdName=134836ccm20暂无昵称, createdTime=Fri Feb 25 16:24:11 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588801, encodeId=4012588801fb, content=2月4号投稿,7号under review，3月16号修回，两个审稿人，每个人大概五六条意见，有一个审稿人要补充氧化应激方面的数据。3月23号修回，25号二次under review，3月31显示收到审稿意见，一直是等待decision，可能是清明节的原因，4月7号收到二次修改的意见，是让补充一下discussion，4月7当天修回，第二天under review，10号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/31/9ef441156d9cc703cacfd553dc8eb7e5.jpg, createdBy=0c895210311, createdName=4475b18am4暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180178, encodeId=15fe21801e860, content=偏重的研究方向：氧化应激;ROS 经验分享：1.7 submittef，1.8号 with editor, 1.9号 under review,接好运啊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 09 06:57:12 CST 2024, time=2024-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907064, encodeId=9e9790e06425, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：炎症;肠道菌群;代谢 经验分享：从投稿到一审结束大约3周，修稿2月后返回，二审又3周，直接接收，10天后online.个人觉得这个杂志审稿效率很高，编辑给的意见很中肯，版面费稍贵，2万多人民币。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bad85222745, createdName=14782f76m64(暂无昵称), createdTime=Fri Dec 11 14:42:22 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166938, encodeId=69ab216693802, content=审稿速度:1.0 经验分享：with editor一个月被desk rejected, 一点意见都没有，真恶心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=bmcmgnmslsb88888, createdTime=Mon Nov 06 01:35:55 CST 2023, time=2023-11-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2122387, encodeId=0c7a212238e2e, content=偏重的研究方向：炎症;药物氧化应激;心血管 经验分享：2023年3月24号投稿，26号让稍微修改下文章，将figure 9以graphic abstract上传后重新投稿，3月27号状态变为“with editor”，28号给了个稿号，with editor等待外审中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94946415536, createdName=ms7000001540185333, createdTime=Wed Mar 29 00:39:50 CST 2023, time=2023-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582040, encodeId=614a582040f5, content=with editor 10多天了，没动静，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7d1625606, createdName=firestar, createdTime=Mon Dec 23 17:19:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550274, encodeId=71405502e478, content=想问下推荐的4个审稿人怎么填写？还有E-mail Address，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68552230471, createdName=121212cbm79(暂无昵称), createdTime=Sat Dec 23 18:16:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013354, encodeId=64f9101335460, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：ROS;Liver disease;Autophagy 经验分享：2021.07.15 Initial Date Submitted 2021.07.16 Under Review 2021.07.23 Required Reviews Completed 2021.08.07 with editor 2021.08.09 Under review 2021.08.30 Required Reviews Completed 2021.08.30 Decision in Process 2021.08.30 Accept 非常高效！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/a185abdd38e94c8ca932a187b8624780/e108d18813c84be0af15f044f2da2f8a.PNG, createdBy=44821626617, createdName=huqiaoting, createdTime=Wed Sep 01 02:28:23 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2019-12-23 firestar

with editor 10多天了，没动静，太慢了

179 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1003572, encodeId=8a5510035e255, content=审稿速度:1.0 经验分享：6.24投稿，大约三周后收到消息补实验，给了两周时间，7月26修回，7月28接受。 这个杂志效率真的是太高了！强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2de25503729, createdName=ms3000000842187804, createdTime=Thu Jul 29 11:46:38 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197254, encodeId=de69119e254a2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：代谢;线粒体 经验分享：好杂志，要求原始数据，对机制要求深入, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aca03683052, createdName=134836ccm20暂无昵称, createdTime=Fri Feb 25 16:24:11 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588801, encodeId=4012588801fb, content=2月4号投稿,7号under review，3月16号修回，两个审稿人，每个人大概五六条意见，有一个审稿人要补充氧化应激方面的数据。3月23号修回，25号二次under review，3月31显示收到审稿意见，一直是等待decision，可能是清明节的原因，4月7号收到二次修改的意见，是让补充一下discussion，4月7当天修回，第二天under review，10号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/31/9ef441156d9cc703cacfd553dc8eb7e5.jpg, createdBy=0c895210311, createdName=4475b18am4暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180178, encodeId=15fe21801e860, content=偏重的研究方向：氧化应激;ROS 经验分享：1.7 submittef，1.8号 with editor, 1.9号 under review,接好运啊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 09 06:57:12 CST 2024, time=2024-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907064, encodeId=9e9790e06425, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：炎症;肠道菌群;代谢 经验分享：从投稿到一审结束大约3周，修稿2月后返回，二审又3周，直接接收，10天后online.个人觉得这个杂志审稿效率很高，编辑给的意见很中肯，版面费稍贵，2万多人民币。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bad85222745, createdName=14782f76m64(暂无昵称), createdTime=Fri Dec 11 14:42:22 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166938, encodeId=69ab216693802, content=审稿速度:1.0 经验分享：with editor一个月被desk rejected, 一点意见都没有，真恶心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=bmcmgnmslsb88888, createdTime=Mon Nov 06 01:35:55 CST 2023, time=2023-11-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2122387, encodeId=0c7a212238e2e, content=偏重的研究方向：炎症;药物氧化应激;心血管 经验分享：2023年3月24号投稿，26号让稍微修改下文章，将figure 9以graphic abstract上传后重新投稿，3月27号状态变为“with editor”，28号给了个稿号，with editor等待外审中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94946415536, createdName=ms7000001540185333, createdTime=Wed Mar 29 00:39:50 CST 2023, time=2023-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582040, encodeId=614a582040f5, content=with editor 10多天了，没动静，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7d1625606, createdName=firestar, createdTime=Mon Dec 23 17:19:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550274, encodeId=71405502e478, content=想问下推荐的4个审稿人怎么填写？还有E-mail Address，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68552230471, createdName=121212cbm79(暂无昵称), createdTime=Sat Dec 23 18:16:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013354, encodeId=64f9101335460, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：ROS;Liver disease;Autophagy 经验分享：2021.07.15 Initial Date Submitted 2021.07.16 Under Review 2021.07.23 Required Reviews Completed 2021.08.07 with editor 2021.08.09 Under review 2021.08.30 Required Reviews Completed 2021.08.30 Decision in Process 2021.08.30 Accept 非常高效！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/a185abdd38e94c8ca932a187b8624780/e108d18813c84be0af15f044f2da2f8a.PNG, createdBy=44821626617, createdName=huqiaoting, createdTime=Wed Sep 01 02:28:23 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2017-12-23 121212cbm79(暂无昵称)

想问下推荐的4个审稿人怎么填写？还有E-mail Address，谢谢

404 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1003572, encodeId=8a5510035e255, content=审稿速度:1.0 经验分享：6.24投稿，大约三周后收到消息补实验，给了两周时间，7月26修回，7月28接受。 这个杂志效率真的是太高了！强烈推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2de25503729, createdName=ms3000000842187804, createdTime=Thu Jul 29 11:46:38 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197254, encodeId=de69119e254a2, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：代谢;线粒体 经验分享：好杂志，要求原始数据，对机制要求深入, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aca03683052, createdName=134836ccm20暂无昵称, createdTime=Fri Feb 25 16:24:11 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588801, encodeId=4012588801fb, content=2月4号投稿,7号under review，3月16号修回，两个审稿人，每个人大概五六条意见，有一个审稿人要补充氧化应激方面的数据。3月23号修回，25号二次under review，3月31显示收到审稿意见，一直是等待decision，可能是清明节的原因，4月7号收到二次修改的意见，是让补充一下discussion，4月7当天修回，第二天under review，10号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/31/9ef441156d9cc703cacfd553dc8eb7e5.jpg, createdBy=0c895210311, createdName=4475b18am4暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180178, encodeId=15fe21801e860, content=偏重的研究方向：氧化应激;ROS 经验分享：1.7 submittef，1.8号 with editor, 1.9号 under review,接好运啊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 09 06:57:12 CST 2024, time=2024-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907064, encodeId=9e9790e06425, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：炎症;肠道菌群;代谢 经验分享：从投稿到一审结束大约3周，修稿2月后返回，二审又3周，直接接收，10天后online.个人觉得这个杂志审稿效率很高，编辑给的意见很中肯，版面费稍贵，2万多人民币。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bad85222745, createdName=14782f76m64(暂无昵称), createdTime=Fri Dec 11 14:42:22 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166938, encodeId=69ab216693802, content=审稿速度:1.0 经验分享：with editor一个月被desk rejected, 一点意见都没有，真恶心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=bmcmgnmslsb88888, createdTime=Mon Nov 06 01:35:55 CST 2023, time=2023-11-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2122387, encodeId=0c7a212238e2e, content=偏重的研究方向：炎症;药物氧化应激;心血管 经验分享：2023年3月24号投稿，26号让稍微修改下文章，将figure 9以graphic abstract上传后重新投稿，3月27号状态变为“with editor”，28号给了个稿号，with editor等待外审中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94946415536, createdName=ms7000001540185333, createdTime=Wed Mar 29 00:39:50 CST 2023, time=2023-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=582040, encodeId=614a582040f5, content=with editor 10多天了，没动静，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7d1625606, createdName=firestar, createdTime=Mon Dec 23 17:19:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550274, encodeId=71405502e478, content=想问下推荐的4个审稿人怎么填写？还有E-mail Address，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68552230471, createdName=121212cbm79(暂无昵称), createdTime=Sat Dec 23 18:16:00 CST 2017, time=2017-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013354, encodeId=64f9101335460, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0 偏重的研究方向：ROS;Liver disease;Autophagy 经验分享：2021.07.15 Initial Date Submitted 2021.07.16 Under Review 2021.07.23 Required Reviews Completed 2021.08.07 with editor 2021.08.09 Under review 2021.08.30 Required Reviews Completed 2021.08.30 Decision in Process 2021.08.30 Accept 非常高效！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/a185abdd38e94c8ca932a187b8624780/e108d18813c84be0af15f044f2da2f8a.PNG, createdBy=44821626617, createdName=huqiaoting, createdTime=Wed Sep 01 02:28:23 CST 2021, time=2021-09-01, status=1, ipAttribution=)]

2021-09-01 huqiaoting

审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3390.0
偏重的研究方向：ROS;Liver disease;Autophagy
经验分享：2021.07.15 Initial Date Submitted
2021.07.16 Under Review
2021.07.23 Required Reviews Completed
2021.08.07 with editor
2021.08.09 Under review
2021.08.30 Required Reviews Completed
2021.08.30 Decision in Process
2021.08.30 Accept
非常高效！！！

113 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务